The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Prostate CancerProstate Cancer Metastatic
Interventions
DIAGNOSTIC_TEST

FAPI PET/CT

This study applies the radiopharmaceutical 18Fluor-FAPI-74 (FAPI) for molecular imaging of FAP expression in vivo with FAPI PET/CT, to assess the presence and distribution of activated Cancer associated fibroblasts as a marker of Tumor Micro-Environment and indirectly as a marker for malignancies.

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT06634173 - The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer | Biotech Hunter | Biotech Hunter